Lowella V Fortuno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lowella V Fortuno has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Angela Y Au
Nutramax Laboratories Veterinary Sciences, Inc, 2208 Lakeside Blvd, Edgewood, MD 21040, USA
1 shared publication - Ann M. Rashmir-Raven
College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, United States
1 shared publication - Carmelita G. Frondoza
Department of Orthopaedic Surgery, Good Samaritan Hospital, Johns Hopkins University, Professional Office Building, 5601 Loch Raven Boulevard, Baltimore, Maryland 21239
1 shared publication - Mark W Grzanna
Nutramax Laboratories Veterinary Sciences, Inc, 2208 Lakeside Blvd, Edgewood, MD 21040, USA
1 shared publication - Stacy L. Ownby
Nutramax Laboratories Consumer Care, Inc., Edgewood, MD 21040, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Springer Nature in Journal of Inflammation
- Vol. 11 (1) , 8
Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination
Osteoarthritis (OA) is characterized by inflammation, joint immobility, and pain. Non-pharmacologic agents modulating pro-inflammatory mediator expression offer considerable promise as safe and effective treatments for OA. We previously determined the anti-inflammatory effect of an avocado/soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG) combination on prostaglandin E2 (PGE2) production and nuclear factor-kappa B (NF-κB) translocation. The aim of this study was to evaluate the effects of ASU + EGCG on pro-inflammatory gene expression.
- 1 January 2014
- Published by Springer Nature in Journal of Inflammation
- Vol. 11 (1) , 8
Open AccessExpression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination
Osteoarthritis (OA) is characterized by inflammation, joint immobility, and pain. Non-pharmacologic agents modulating pro-inflammatory mediator expression offer considerable promise as safe and effective treatments for OA. We previously determined the anti-inflammatory effect of an avocado/soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG) combination on prostaglandin E2 (PGE2) production and nuclear factor-kappa B (NF-κB) translocation. The aim of this study was to evaluate the effects of ASU + EGCG on pro-inflammatory gene expression.